Follow-up of Helicobacter pylori status by using 13C-urea breath test in nonulcer dyspeptic patients after eradication therapy.
BACKGROUND
The role of eradication therapy is still controversial in H. pylori-related nonulcer dyspepsia (NUD). The aim of this study was to follow up the H. pylori status after eradication therapy in patients with NUD by using l3C-urea breath test (UBT).


METHODS
Patients with a clinical and endoscopic diagnosis of NUD were included. H. pylori infection was established by endoscopic biopsies and 13C-UBT. Patients with H. pylori infection then received a quadruple therapy with colloidal bismuth subcitrate, metronidazole, tetracycline and lansoprazole. Two months after completion of therapy, endoscopic biopsies and 13C-UBT were performed again to confirm eradication. A follow-up 13C-UBT was carried out again in one year to detect recurrence of H. pylori infection.


RESULTS
Eighty-eight of the 148 patients (59.5%) were found to have H. pylori infection by both endoscopic biopsies and 13C-UBT. Anti-H. pylori therapy was given for 55 patients and proved successful in 33 of them two months after the end of therapy. However, recurrence was found one year later in three of these 33 cases, making a recurrence rate of 9.1% (3/33). Three of the 22 cases with unsuccessful eradication were found to have H. pylori eradication at one year by follow-up 13C-UBT. One of the 33 H. pylori-positive patients without anti-H. pylori therapy, who had negative 13C-UBT in one year follow-up, was found taking a high dose and long period of antibiotics.


CONCLUSIONS
The recurrence rate of H. pylori infection in our study was higher than that in the Western population. Delayed eradication of H. pylori may occur after anti-H. pylori therapy. Spontaneous eradication is rare in patients not receiving anti-H. pylori eradication.
Peng
N J
NJ
Department of Nuclear Medicine, Veterans General Hospital, Kaohsiung, Taiwan, ROC.
Hsu
P I
PI
Lee
S C
SC
Tseng
H H
HH
Huang
W K
WK
Tsay
D G
DG
Lo
G H
GH
Lin
C K
CK
Cheng
J S
JS
Lai
K H
KH
D001944:Breath Tests; D004415:Dyspepsia / Q000382:microbiology*; D005500:Follow-Up Studies; D016481:Helicobacter Infections / Q000175:diagnosis* / Q000628:therapy; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D011446:Prospective Studies; D012008:Recurrence; D014508:Urea / Q000378:metabolism*
D014508:Urea